In addition to p53, it has been reported that the ERK signaling pathway can be activated by cisplatin and is a key pathway of p53-dependent apoptosis induced by cisplatin in many cancer cells, including lung cancer cells [29,40,41]. The gene discussed is TP53; the disease is lung carcinoma.